PATH
Menu

Filter browse results

Total results with these characteristics: 185

Subject: Health technologies > Vaccine delivery

Page 10 of 10
Vaccines in Fast-Dissolving Tablets: Novel Product Format to Ensure Vaccine Effectiveness, Affordability, and Ease of Use

This fact sheet provides an overview of PATH's work in developing fast-dissolving tablet vaccine formulations manufactured using a standard lyophilization process. The tablets are packaged in unit-dose blisters, offering an inexpensive, scalable, and easy-to-use presentation for live attenuated vaccines containing single or multiple bacterial strains. Further, the stackable design may minimize product volume and thus the space required for storage and transport, resulting in significant savings for health systems and cold chains.

Publication date: March 2012

Region: Global

Vaccines in the Uniject™ Injection System

Part of the Technology Updates series, this fact sheet describes PATH's work on the Uniject™ injection system for use with vaccines.

Publication date: August 2013

Region: Global

Part of series: Technology Updates

Vietnam: Demonstrating Innovative Health Supply Chain Solutions

This document describes how project Optimize is collaborating with Vietnam’s National Institute of Hygiene and Epidemiology to demonstrate innovations in the supply chain that can help to meet the demands of an increasingly large and costly portfolio of vaccines.

Publication date: July 2012

Region: Asia

Vietnam’s Immunization Registries Go Online

In Vietnam, project Optimize worked with government and software partners to help introduce a digital immunization registry. This brief describes how the registry allowed the health system to better track children due for vaccination and shortened the time required for recording and reporting immunizations compared to the existing paper-based registry.

Publication date: January 2013

Region: Asia

Yellow Fever Vaccination: The Potential of Dose-Sparing to Increase Vaccine Supply and Availability

PATH commissioned this report in an effort to evaluate whether dose-sparing, possibly through the intradermal (ID) route, could improve the availability of yellow fever vaccine globally. The authors identify and discuss potential benefits, possible obstacles, and associated costs of dose-sparing as a vaccine delivery strategy. In addition, the report includes an assessment of which settings would be most appropriate and to what extent novel ID delivery devices, such as needle-free disposable-syringe jet injectors, would help to facilitate its successful implementation.

Author: Hickling J, Jones R

Publication date: April 2013

Region: Global

Page 10 of 10